Cargando…

Proteotranscriptomics of ocular adnexal B-cell lymphoma reveals an oncogenic role of alternative splicing and identifies a diagnostic marker

BACKGROUND: Ocular adnexal B-cell lymphoma (OABL) is a rare subtype of non-Hodgkin lymphoma. The molecular characteristics of OABL remain poorly understood. We performed an integrated study to investigate the proteotranscriptome landscape and identify novel molecular characteristics and biomarkers o...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Jiahao, Zhu, Tianyu, Lin, Huimin, Liu, Zhen, Zhou, Min, Yu, Ziyao, Zhou, Xiaowen, Song, Xin, Wang, Yefei, Jia, Renbing, Fan, Xianqun, Zhou, Yixiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338531/
https://www.ncbi.nlm.nih.gov/pubmed/35906682
http://dx.doi.org/10.1186/s13046-022-02445-8
_version_ 1784759988787347456
author Shi, Jiahao
Zhu, Tianyu
Lin, Huimin
Liu, Zhen
Zhou, Min
Yu, Ziyao
Zhou, Xiaowen
Song, Xin
Wang, Yefei
Jia, Renbing
Fan, Xianqun
Zhou, Yixiong
author_facet Shi, Jiahao
Zhu, Tianyu
Lin, Huimin
Liu, Zhen
Zhou, Min
Yu, Ziyao
Zhou, Xiaowen
Song, Xin
Wang, Yefei
Jia, Renbing
Fan, Xianqun
Zhou, Yixiong
author_sort Shi, Jiahao
collection PubMed
description BACKGROUND: Ocular adnexal B-cell lymphoma (OABL) is a rare subtype of non-Hodgkin lymphoma. The molecular characteristics of OABL remain poorly understood. We performed an integrated study to investigate the proteotranscriptome landscape and identify novel molecular characteristics and biomarkers of OABL. METHODS: Integrated quantitative proteome and transcriptome were performed on 40 OABL 12 idiopathic orbital inflammation, 6 reactive lymphoid hyperplasia, and 13 aesthetic orbital plastic surgery specimens. Complete clinicopathologic and prognostic data of the patients were recorded. RESULTS: We identified high global protein-mRNA concordance as a novel characteristic of OABL. High concordance was related to OABL recurrence. By integrated expression profile, motif enrichment and trend analysis, we found that alternative splicing is inflammation-independently dysregulated in OABL. After portraying the aberrant alternative splicing event landscape, we demonstrated the oncogenic role of ADAR, a core splicing regulator that regulates the splicing of Rho GTPase and cell cycle members. We found that ADAR regulates cell proliferation and Rho GTPase inhibitor sensitivity of lymphoma. We identified DNAJC9 as a potential biomarker for OABL in proteomic analyses. Immunohistochemistry and immunofluorescent staining showed the nuclear staining of DNAJC9 was significantly higher in extranodal marginal zone lymphomas compared with inflammation specimens. CONCLUSIONS: These results provide an integrated gene expression profiling and demonstrate that high global protein-mRNA concordance is a prognosis-related molecular characteristic of OABL. We portray the alternative splicing events landscape of OABL, and reveal the oncogenic role of ADAR. We identified strong nuclear staining of DNAJC9 as a promising pathology diagnostic biomarker for extranodal marginal zone lymphomas. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-022-02445-8.
format Online
Article
Text
id pubmed-9338531
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93385312022-07-31 Proteotranscriptomics of ocular adnexal B-cell lymphoma reveals an oncogenic role of alternative splicing and identifies a diagnostic marker Shi, Jiahao Zhu, Tianyu Lin, Huimin Liu, Zhen Zhou, Min Yu, Ziyao Zhou, Xiaowen Song, Xin Wang, Yefei Jia, Renbing Fan, Xianqun Zhou, Yixiong J Exp Clin Cancer Res Research BACKGROUND: Ocular adnexal B-cell lymphoma (OABL) is a rare subtype of non-Hodgkin lymphoma. The molecular characteristics of OABL remain poorly understood. We performed an integrated study to investigate the proteotranscriptome landscape and identify novel molecular characteristics and biomarkers of OABL. METHODS: Integrated quantitative proteome and transcriptome were performed on 40 OABL 12 idiopathic orbital inflammation, 6 reactive lymphoid hyperplasia, and 13 aesthetic orbital plastic surgery specimens. Complete clinicopathologic and prognostic data of the patients were recorded. RESULTS: We identified high global protein-mRNA concordance as a novel characteristic of OABL. High concordance was related to OABL recurrence. By integrated expression profile, motif enrichment and trend analysis, we found that alternative splicing is inflammation-independently dysregulated in OABL. After portraying the aberrant alternative splicing event landscape, we demonstrated the oncogenic role of ADAR, a core splicing regulator that regulates the splicing of Rho GTPase and cell cycle members. We found that ADAR regulates cell proliferation and Rho GTPase inhibitor sensitivity of lymphoma. We identified DNAJC9 as a potential biomarker for OABL in proteomic analyses. Immunohistochemistry and immunofluorescent staining showed the nuclear staining of DNAJC9 was significantly higher in extranodal marginal zone lymphomas compared with inflammation specimens. CONCLUSIONS: These results provide an integrated gene expression profiling and demonstrate that high global protein-mRNA concordance is a prognosis-related molecular characteristic of OABL. We portray the alternative splicing events landscape of OABL, and reveal the oncogenic role of ADAR. We identified strong nuclear staining of DNAJC9 as a promising pathology diagnostic biomarker for extranodal marginal zone lymphomas. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-022-02445-8. BioMed Central 2022-07-30 /pmc/articles/PMC9338531/ /pubmed/35906682 http://dx.doi.org/10.1186/s13046-022-02445-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Shi, Jiahao
Zhu, Tianyu
Lin, Huimin
Liu, Zhen
Zhou, Min
Yu, Ziyao
Zhou, Xiaowen
Song, Xin
Wang, Yefei
Jia, Renbing
Fan, Xianqun
Zhou, Yixiong
Proteotranscriptomics of ocular adnexal B-cell lymphoma reveals an oncogenic role of alternative splicing and identifies a diagnostic marker
title Proteotranscriptomics of ocular adnexal B-cell lymphoma reveals an oncogenic role of alternative splicing and identifies a diagnostic marker
title_full Proteotranscriptomics of ocular adnexal B-cell lymphoma reveals an oncogenic role of alternative splicing and identifies a diagnostic marker
title_fullStr Proteotranscriptomics of ocular adnexal B-cell lymphoma reveals an oncogenic role of alternative splicing and identifies a diagnostic marker
title_full_unstemmed Proteotranscriptomics of ocular adnexal B-cell lymphoma reveals an oncogenic role of alternative splicing and identifies a diagnostic marker
title_short Proteotranscriptomics of ocular adnexal B-cell lymphoma reveals an oncogenic role of alternative splicing and identifies a diagnostic marker
title_sort proteotranscriptomics of ocular adnexal b-cell lymphoma reveals an oncogenic role of alternative splicing and identifies a diagnostic marker
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338531/
https://www.ncbi.nlm.nih.gov/pubmed/35906682
http://dx.doi.org/10.1186/s13046-022-02445-8
work_keys_str_mv AT shijiahao proteotranscriptomicsofocularadnexalbcelllymphomarevealsanoncogenicroleofalternativesplicingandidentifiesadiagnosticmarker
AT zhutianyu proteotranscriptomicsofocularadnexalbcelllymphomarevealsanoncogenicroleofalternativesplicingandidentifiesadiagnosticmarker
AT linhuimin proteotranscriptomicsofocularadnexalbcelllymphomarevealsanoncogenicroleofalternativesplicingandidentifiesadiagnosticmarker
AT liuzhen proteotranscriptomicsofocularadnexalbcelllymphomarevealsanoncogenicroleofalternativesplicingandidentifiesadiagnosticmarker
AT zhoumin proteotranscriptomicsofocularadnexalbcelllymphomarevealsanoncogenicroleofalternativesplicingandidentifiesadiagnosticmarker
AT yuziyao proteotranscriptomicsofocularadnexalbcelllymphomarevealsanoncogenicroleofalternativesplicingandidentifiesadiagnosticmarker
AT zhouxiaowen proteotranscriptomicsofocularadnexalbcelllymphomarevealsanoncogenicroleofalternativesplicingandidentifiesadiagnosticmarker
AT songxin proteotranscriptomicsofocularadnexalbcelllymphomarevealsanoncogenicroleofalternativesplicingandidentifiesadiagnosticmarker
AT wangyefei proteotranscriptomicsofocularadnexalbcelllymphomarevealsanoncogenicroleofalternativesplicingandidentifiesadiagnosticmarker
AT jiarenbing proteotranscriptomicsofocularadnexalbcelllymphomarevealsanoncogenicroleofalternativesplicingandidentifiesadiagnosticmarker
AT fanxianqun proteotranscriptomicsofocularadnexalbcelllymphomarevealsanoncogenicroleofalternativesplicingandidentifiesadiagnosticmarker
AT zhouyixiong proteotranscriptomicsofocularadnexalbcelllymphomarevealsanoncogenicroleofalternativesplicingandidentifiesadiagnosticmarker